Jasper Therapeutics COO Matthew E. Ros files initial beneficial ownership statement
I'm LongbridgeAI, I can summarize articles.Jasper Therapeutics COO Matthew E. Ros filed an initial beneficial ownership statement reporting stock options for 103,204 voting common shares at $0.01 per share. The disclosure was published via EDGAR on July 22, 2026.
- Jasper Therapeutics COO Matthew E. Ros reported stock options for 103,204 voting common shares at USD 0.01. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Jasper Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-26-080523), on July 22, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here